Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hydroliq is a Swiss-based healthcare and medtech company specializing in the development of innovative, alcohol-free disinfection solutions. The company utilizes a proprietary electrochemical activation (ECA) process to produce pH-neutral, water-based disinfectants that are highly effective against a broad spectrum of pathogens, including bacteria, viruses, and fungi. Unlike traditional chemical disinfectants, Hydroliq's products are non-toxic, dermatologically tested, and environmentally friendly, making them suitable for use in clinical, industrial, and private settings. Their portfolio includes specialized solutions for surface disinfection, wound care, and water treatment, focusing on high safety standards and sustainability. Hydroliq's technology is designed to provide long-term protection without the risk of developing microbial resistance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hydroliq.